Sherry Korczynski, Chief Commercial Officer at Aquestive Therapeutics, Inc. (AQST), sold 8,750 shares at $5.22 ($46K) on 2026-09-09, disclosed to the SEC on 2026-09-11.
Scheduled sale ($46k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.